Literature DB >> 31301400

Axon injury signaling and compartmentalized injury response in glaucoma.

Stephanie B Syc-Mazurek1, Richard T Libby2.   

Abstract

Axonal degeneration is an active, highly controlled process that contributes to beneficial processes, such as developmental pruning, but also to neurodegeneration. In glaucoma, ocular hypertension leads to vision loss by killing the output neurons of the retina, the retinal ganglion cells (RGCs). Multiple processes have been proposed to contribute to and/or mediate axonal injury in glaucoma, including: neuroinflammation, loss of neurotrophic factors, dysregulation of the neurovascular unit, and disruption of the axonal cytoskeleton. While the inciting injury to RGCs in glaucoma is complex and potentially heterogeneous, axonal injury is ultimately thought to be the key insult that drives glaucomatous neurodegeneration. Glaucomatous neurodegeneration is a complex process, with multiple molecular signals contributing to RGC somal loss and axonal degeneration. Furthermore, the propagation of the axonal injury signal is complex, with injury triggering programs of degeneration in both the somal and axonal compartment. Further complicating this process is the involvement of multiple cell types that are known to participate in the process of axonal and neuronal degeneration after glaucomatous injury. Here, we review the axonal signaling that occurs after injury and the molecular signaling programs currently known to be important for somal and axonal degeneration after glaucoma-relevant axonal injuries.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Apoptosis; Axon; Axonopathy; Dendritic remodeling; Intraocular pressure; Neuroprotection; Optic neuropathy; Synaptic loss

Mesh:

Year:  2019        PMID: 31301400      PMCID: PMC6898776          DOI: 10.1016/j.preteyeres.2019.07.002

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   21.198


  259 in total

1.  ER stress triggers apoptosis by activating BH3-only protein Bim.

Authors:  Hamsa Puthalakath; Lorraine A O'Reilly; Priscilla Gunn; Lily Lee; Priscilla N Kelly; Nicholas D Huntington; Peter D Hughes; Ewa M Michalak; Jennifer McKimm-Breschkin; Noburo Motoyama; Tomomi Gotoh; Shizuo Akira; Philippe Bouillet; Andreas Strasser
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

2.  DLK initiates a transcriptional program that couples apoptotic and regenerative responses to axonal injury.

Authors:  Trent A Watkins; Bei Wang; Sarah Huntwork-Rodriguez; Jing Yang; Zhiyu Jiang; Jeffrey Eastham-Anderson; Zora Modrusan; Joshua S Kaminker; Marc Tessier-Lavigne; Joseph W Lewcock
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

3.  The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD+ Cleavage Activity that Promotes Pathological Axonal Degeneration.

Authors:  Kow Essuman; Daniel W Summers; Yo Sasaki; Xianrong Mao; Aaron DiAntonio; Jeffrey Milbrandt
Journal:  Neuron       Date:  2017-03-22       Impact factor: 17.173

4.  Calpains mediate axonal cytoskeleton disintegration during Wallerian degeneration.

Authors:  Marek Ma; Toby A Ferguson; Kathleen M Schoch; Jian Li; Yaping Qian; Frances S Shofer; Kathryn E Saatman; Robert W Neumar
Journal:  Neurobiol Dis       Date:  2013-03-28       Impact factor: 5.996

5.  Early gene expression changes in the retinal ganglion cell layer of a rat glaucoma model.

Authors:  Ying Guo; Elaine C Johnson; William O Cepurna; Jennifer A Dyck; Tom Doser; John C Morrison
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-18       Impact factor: 4.799

6.  Long-term survival of retinal ganglion cells following optic nerve section in adult bcl-2 transgenic mice.

Authors:  M C Cenni; L Bonfanti; J C Martinou; G M Ratto; E Strettoi; L Maffei
Journal:  Eur J Neurosci       Date:  1996-08       Impact factor: 3.386

7.  The regulation of p53 up-regulated modulator of apoptosis by JNK/c-Jun pathway in β-amyloid-induced neuron death.

Authors:  Rumana Akhter; Priyankar Sanphui; Hrishita Das; Pampa Saha; Subhas Chandra Biswas
Journal:  J Neurochem       Date:  2015-04-28       Impact factor: 5.372

8.  Morphologic changes in the lamina cribrosa correlated with neural loss in open-angle glaucoma.

Authors:  H A Quigley; R M Hohman; E M Addicks; R W Massof; W R Green
Journal:  Am J Ophthalmol       Date:  1983-05       Impact factor: 5.258

Review 9.  Caspases in retinal ganglion cell death and axon regeneration.

Authors:  Chloe N Thomas; Martin Berry; Ann Logan; Richard J Blanch; Zubair Ahmed
Journal:  Cell Death Discov       Date:  2017-07-03

10.  MyD88-5 links mitochondria, microtubules, and JNK3 in neurons and regulates neuronal survival.

Authors:  Younghwa Kim; Ping Zhou; Liping Qian; Jen-Zen Chuang; Jessica Lee; Chenjian Li; Costantino Iadecola; Carl Nathan; Aihao Ding
Journal:  J Exp Med       Date:  2007-08-27       Impact factor: 14.307

View more
  29 in total

Review 1.  Inducible rodent models of glaucoma.

Authors:  Iok-Hou Pang; Abbot F Clark
Journal:  Prog Retin Eye Res       Date:  2019-09-23       Impact factor: 21.198

Review 2.  Long Non-Coding RNAs in Retinal Ganglion Cell Apoptosis.

Authors:  Ningzhi Zhang; Wenye Cao; Xuejun He; Yiqiao Xing; Ning Yang
Journal:  Cell Mol Neurobiol       Date:  2022-02-28       Impact factor: 5.046

3.  Ouabain-Na+/K+-ATPase Signaling Regulates Retinal Neuroinflammation and ROS Production Preventing Neuronal Death by an Autophagy-Dependent Mechanism Following Optic Nerve Axotomy In Vitro.

Authors:  Thalita Mázala-de-Oliveira; Camila Saggioro de Figueiredo; Gustavo de Rezende Corrêa; Mayra Santos da Silva; Renan Lyra Miranda; Mariana Almeida de Azevedo; Marcelo Cossenza; Aline Araujo Dos Santos; Elizabeth Giestal-de-Araujo
Journal:  Neurochem Res       Date:  2021-11-16       Impact factor: 3.996

4.  Core transcription programs controlling injury-induced neurodegeneration of retinal ganglion cells.

Authors:  Feng Tian; Yuyan Cheng; Songlin Zhou; Qianbin Wang; Aboozar Monavarfeshani; Kun Gao; Weiqian Jiang; Riki Kawaguchi; Qing Wang; Mingjun Tang; Ryan Donahue; Huyan Meng; Yu Zhang; Anne Jacobi; Wenjun Yan; Jiani Yin; Xinyi Cai; Zhiyun Yang; Shane Hegarty; Joanna Stanicka; Phillip Dmitriev; Daniel Taub; Junjie Zhu; Clifford J Woolf; Joshua R Sanes; Daniel H Geschwind; Zhigang He
Journal:  Neuron       Date:  2022-06-28       Impact factor: 18.688

5.  Astrocytes modulate neurodegenerative phenotypes associated with glaucoma in OPTN(E50K) human stem cell-derived retinal ganglion cells.

Authors:  Cátia Gomes; Kirstin B VanderWall; Yanling Pan; Xiaoyu Lu; Sailee S Lavekar; Kang-Chieh Huang; Clarisse M Fligor; Jade Harkin; Chi Zhang; Theodore R Cummins; Jason S Meyer
Journal:  Stem Cell Reports       Date:  2022-06-16       Impact factor: 7.294

Review 6.  Multi-Target Effects of ß-Caryophyllene and Carnosic Acid at the Crossroads of Mitochondrial Dysfunction and Neurodegeneration: From Oxidative Stress to Microglia-Mediated Neuroinflammation.

Authors:  Roberto Iorio; Giuseppe Celenza; Sabrina Petricca
Journal:  Antioxidants (Basel)       Date:  2022-06-18

Review 7.  Multifactorial Pathogenic Processes of Retinal Ganglion Cell Degeneration in Glaucoma towards Multi-Target Strategies for Broader Treatment Effects.

Authors:  Gülgün Tezel
Journal:  Cells       Date:  2021-06-02       Impact factor: 6.600

8.  Retinal ganglion cell survival after severe optic nerve injury is modulated by crosstalk between Jak/Stat signaling and innate immune responses in the zebrafish retina.

Authors:  Si Chen; Kira L Lathrop; Takaaki Kuwajima; Jeffrey M Gross
Journal:  Development       Date:  2021-10-26       Impact factor: 6.868

Review 9.  Extracellular vesicle therapy for retinal diseases.

Authors:  Ben Mead; Stanislav Tomarev
Journal:  Prog Retin Eye Res       Date:  2020-03-10       Impact factor: 19.704

Review 10.  Molecular regulation of neuroinflammation in glaucoma: Current knowledge and the ongoing search for new treatment targets.

Authors:  Gülgün Tezel
Journal:  Prog Retin Eye Res       Date:  2021-08-01       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.